Reviewed listing: NASDAQ:XRX · Analysis dated Oct 17, 2026
The underlying information has changed since this analysis. This earlier assessment has not yet been updated for those changes. It refers to the analysis date and original reviewed price shown here.
How does the company make money?
Xerox sells and services printers, copiers, and printing systems for businesses worldwide. It also provides consumables, document management, and IT services.
What supports the business?
Xerox continues to earn money from maintenance, supplies, and services after selling equipment. The combination with Lexmark offers potential for savings, although the business is currently shrinking on a comparable basis.
What could improve?
If Xerox retains its customers, cuts costs, and reduces debt, the stock could gain significantly. The announced cost savings alone do not guarantee this recovery.
How is the stock price assessed?
This assessment refers to the analysis and its quoted price shown here. It is not a live quote or a personal recommendation to buy.
Whether enough cash remains after interest, investment, and debt repayment is too uncertain to support a favorable price assessment. The price checked was 2.47 USD per share as of 16. October 2026, not a real-time quote.
What is the main risk?
Falling demand, high debt, and cash outflows after investment in the first half make Xerox risky. Further substantial losses, including a total loss, are possible; additional shares could reduce your ownership stake.
What is the overall assessment?
Currently not a compelling investment opportunity: Xerox must address declining demand, high debt, and weak cash inflow at the same time. Even at 2.47 USD, a favorable price has not been adequately established.
Continue exploring this stock in your account
A free Marqora account gives you the detailed analysis with further evidence and lets you compare and save stocks. Your selected stock is kept when you sign in or register.
Open the full analysis in a free account →
Already have an account? Sign inSources used in the analysis
- Original source 1 · investors.xerox.com · Aug 06, 2026
- Original source 2 · investors.xerox.com · Jul 30, 2026
- Original source 3 · investors.xerox.com · Jan 29, 2026
- Original source 4 · investors.xerox.com · Aug 05, 2026
- Original source 5 · investors.xerox.com · Oct 15, 2026
- Original source 6 · api-v4.fcsapi.com